InterventionsReview
Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change
The Lancet Neurology
- Anti-amyloid monoclonal antibodies
- Alzheimer's disease
- Alzheimer's disease neuropathological change
- Humans
The paper
Graff-Radford J, Karliner L, Barnes DE et al.
The Lancet Neurology · 9 Sep 2026
